on 07 Aug 2018
Last Applicant/ Owned by
530 Fairview Avenue North
Seattle
WA
98109
Serial Number
87977815 filed on 28th Mar 2017
Registration Number
5537412 registered on 07th Aug 2018
Correspondent Address
ALYSSA WORSHAM
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics aRead More
Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes and industrial quality control processes; chemical screening analysis for others
05th May 2017
05th May 2017
Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
30th Jan 2018
30th Jan 2018
Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
30th Aug 2017
30th Aug 2017
No 87977815
No Service Mark
No 31353-TM1038
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
26.17.08 -
A single line, band, bar or diagonal
The mark consists of the word "nanoString" with a line below the word containing circles.
| Status Date | Action Taken |
|---|---|
| 07th Aug 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 18th Mar 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 07th Aug 2018 | REGISTERED-PRINCIPAL REGISTER |
| 30th Jun 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 29th Jun 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 09th Jun 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 08th Jun 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 08th Jun 2018 | DIVISIONAL PROCESSING COMPLETE |
| 08th Jun 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| 04th Jun 2018 | TEAS STATEMENT OF USE RECEIVED |
